Joachim Reischl

Joachim Reischl is an experienced leader in the field of diagnostics and precision medicine, currently serving as Vice President of External Innovation Diagnostics and Head of Innovation at Danaher Corporation. Previously, Joachim held significant positions at AstraZeneca, including Vice President and Head of Diagnostic Sciences and Vice President for Precision Medicine Policy, Portfolio, and Externalization. At Bayer Pharma, Joachim was responsible for the global biomarker strategy and development. Joachim Reischl's educational background includes a PhD in Molecular Genetics from the University of Bayreuth, and a research stay as an HHMI student at The Rockefeller University.